retatrutide vs semaglutide weight loss comparison Semaglutide: Triple vs Single Agonist - Which Is Better? | PPW Semaglutide vs tirzepatide vs retatrutide:

doi:10.1159/000053183 Heffernan M, Summers RJ, Thorburn A, et al

Tirzepatide: A Dual GLP-1/GIP Receptor Agonist Tirzepatide is a novel dual agonist at both GIP and GLP-1 receptors that received approval for the treatment of T2D in 2022

Clinical trials involving individuals with type 1 and type 2 diabetes will be conducted to evaluate the effects of exogenous C-peptide administration on glycemic control, insulin sensitivity, and microvascular complications

GLP-1 medications slow gastric emptying, which often leads to nausea and vomiting, especially early in treatment

Its effects on the HGF/c-Met pathway, while beneficial for neural repair, require careful consideration regarding long-term use

2 (download XLSX Numerical data for titration experiments Source Data Fig